20May 2022
Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility

Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility

Alzheimer's disease (AD) to enable timely and accurate diagnosis, estimate future burden and support therapeutic trials. Current cerebrospinal fluid and molecular neuroimaging biomarkers fulfil these criteria but lack the scalability and simplicity necessary for widespread application. Nevertheless, blood biomarkers of adequate effectiveness have the potential to act as first-line diagnostic and prognostic tools and offer the possibility of extensive population screening and use that is not limited to specialized centres. The study highlights unique ethical, clinical and analytical challenges and outline the steps that need to be taken to standardize inter-laboratory and inter-assay measurements.

  • #neurology

Like

Save

Share